COVID-19 has highlighted how the world's largest pharmaceutical companies (through patent and intellectual property control), government intervention and the wealth of a country, can impede global public health solutions during pandemics. In response, there is now a push for "open-source" pharma - the patent-free collaboration and sharing of vaccine data, research and development.
EU to block vaccine exports amid AstraZeneca delivery spat - DW News (31 Jan, 2021).
EU stops short of coronavirus export ban - BBC (27 Mar, 2021).
In early October 2020, India and South Africa made a proposal to the World Trade Organisation to waiver the international intellectual property rights agreement (“TRIPS” agreement) during the pandemic to increase the production of COVID-19 vaccines and related therapeutics/equipment for low-wealth countries. Fast forward more than 18 months, while different versions have been debated, still no agreement has been reached. Major discussions take place again in June 2022.
COVAX Humanitarian Buffer Explained (1 min.).
This full-text database of Australian newspapers is recommended for researching further information on COVID-19 related issues. It includes The Australian, The Age and Herald Sun newspapers as well many others.
Please contact the Library for helping researching newspaper articles. The below guide will also be of use.